SunWay Biotech has a longstanding commitment to Corporate Social Responsibility (CSR). Last week, SunWay and four other MISA members provided grants to the “Cochlear Implant Specialty Program” of Tri-Service General Hospital this November for patients with severe hearing loss to receive subsidies for cochlear implant surgery.
According to statistics from the Ministry of Health and Welfare, until October 2022, there are still more than 20,000 people with severe or extremely severe hearing loss, including young children. They all look forward to hearing more sounds from this world. However, the hardware expenses required for cochlear implant surgery are costly. For many people with hearing loss and their families, it is not only a new hope but also a considerable medical burden. Through our CSR program, SunWay and four other MISA members provide grants to the “Cochlear Implant Specialty Account” of the Tri-Service General Hospital. We truly believe that it can bring those people a better future.
